can you take tirzepatide with levothyroxine and Tirzepatide: Drug Interaction Safety Tirzepatide and Hypothyroidism | Optimize

10.1161/CIRCULATIONAHA.117.029166 131

The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising

Chronic low-grade inflammation contributes to obesity-related comorbidities [123, 124], and the MD has consistently demonstrated immunomodulatory effects, even in the absence of weight loss [123, 124]

Weight loss difficulties can be caused by a number of different conditions

dosing with B12 for energy